Categories: Health

Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum

 | Source: Cullinan Therapeutics, Inc.

CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on Tuesday, September 16, 2025, at 9:30 a.m. ET.

A webcast of the fireside chat will be available under the Events and Presentations section of the Company’s investor relations website at https://investors.cullinantherapeutics.com/events.

About Cullinan Therapeutics

Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company dedicated to creating new standards of care for patients. Cullinan has strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both autoimmune diseases and cancer. Cullinan’s portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class. Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of autoimmune and cancer indications. We push conventional boundaries from candidate selection to differentiated therapeutic, applying rigorous go/no go criteria at each stage of development to fast-track only the most promising molecules to the clinic and, ultimately, commercialization. With deep scientific expertise, our teams exercise creativity and urgency to deliver on our promise to bring new therapeutic solutions to patients. Learn more about Cullinan at https://cullinantherapeutics.com/, and follow us on LinkedIn and X.

Contacts:

Investor Relations
Nick Smith
+1 401.241.3516
nsmith@cullinantx.com

Media
Rose Weldon
+1 215.801.7644
rweldon@cullinantx.com

GlobeNews Wire

Recent Posts

Natural History Museum Abu Dhabi to Open in Saadiyat Cultural District on 22 November

ABU DHABI, UAE, Oct. 22, 2025 /PRNewswire/ -- The Natural History Museum Abu Dhabi will…

16 minutes ago

Internet Watch Foundation and Public Interest Registry Extend Online Safety Initiative to Disrupt Criminal ‘brands’ Selling Child Sexual Abuse

A new sponsorship programme aims to help domain registrars 'disrupt' criminal businesses Criminals running commercial…

16 minutes ago

FuelBuddy Expands into Zimbabwe and Zambia, Strengthening Its Footprint in Africa

FuelBuddy, a leading global mobile fuel distribution platform that provides sustainable solutions for businesses, today…

2 hours ago

Dhruva Advisors Unveils Second Edition of 'Investing in India 2025': A Comprehensive Guide for Global Investors

Dhruva Advisors, one of India’s leading homegrown tax and regulatory consulting firms, has released the…

2 hours ago

Hill’s Pet Nutrition Announces 2025 Hill’s Global Symposium – “Strong Science, Long Lives” – to Advance Senior Pet Care

Registration now open for veterinary professionals in Asia and Australia to access the latest insights…

2 hours ago

ILO DIRECTOR-GENERAL COMMENDS STEVEN SIM’S LEADERSHIP IN ADVANCING ASEAN’S SKILLS AGENDA AT GSF 2025

KUALA LUMPUR, Malaysia, Oct. 22, 2025 /PRNewswire/ -- Malaysia today etched a defining milestone in…

2 hours ago